ASST FATEBENEFRATELLI SACCO

🇮🇹Italy
Ownership
Private
Established
2015-01-01
Employees
-
Market Cap
-
Website
https://www.asst-fbf-sacco.it
Clinical Trials
Related News

Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects

Phase 4
Completed
Conditions
HIV Infections
Interventions
Drug: Maraviroc
First Posted Date
2009-04-21
Last Posted Date
2013-04-30
Lead Sponsor
ASST Fatebenefratelli Sacco
Target Recruit Count
100
Registration Number
NCT00884858
Locations
🇮🇹

Servizio Regionale di Immunologia Clinica e Tipizzazione Tissutale, Azienda Ospedaliero-Universitaria, Torrette di Ancona, AN, Italy

🇮🇹

Clinica di Malattie Infettive, Policlinico, Universita' degli Studi, Bari, BA, Italy

🇮🇹

Clinica di Malattie Infettive e Tropicali, Università degli Studi di Brescia, Spedali civili, Brescia, BS, Italy

and more 17 locations

Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists

First Posted Date
2007-06-26
Last Posted Date
2007-06-26
Lead Sponsor
ASST Fatebenefratelli Sacco
Target Recruit Count
100
Registration Number
NCT00491933
Locations
🇮🇹

Rheumatology Unit, Ospedale L. Sacco Polo Universitario, Milano, Italy

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy